期刊文献+

Primary clear cell carcinoma in the liver: CT and MRI findings 被引量:30

Primary clear cell carcinoma in the liver: CT and MRI findings
下载PDF
导出
摘要 AIM: To retrospectively analyze the computed tomography (CT) and magnetic resonance imaging (MRI) appearances of primary clear cell carcinoma of the liver (PCCCL) and compare the imaging appearances of PCCCL and common type hepatocellular carcinoma (CHCC) to determine whether any differences exist between the two groups. METHODS: Twenty cases with pathologically proven PCCCL and 127 cases with CHCC in the Second Affiliated Hospital of Sun Yat-sen University were included in this study. CT or MRI images from these patients were retrospectively analyzed. The following imaging findings were reviewed: the presence of liver cirrhosis, tumor size, the enhancement pattern on dynamic contrast scanning, the presence of pseudo capsules, tumor rupture, portal vein thrombosis and lymph node metastasis. RESULTS: Both PCCCL and CHCC were prone to occur in patients with liver cirrhosis, the association rate of liver cirrhosis was 80.0% and 78.7%, respectively (P > 0.05). The mean sizes of PCCCL and CHCC tumors were (7.28 ± 4.25) cm and (6.96 ± 3.98) cm, respectively. Small HCCs were found in 25.0% (5/20) of PCCCL and 19.7% (25/127) of CHCC cases. No significant differences in mean size and ratio of small HCCs were found between the two groups (P = 0.658 and 0.803, respectively). Compared with CHCC patients, PCCCL patients were more prone to form pseudo capsules (49.6% vs 75.0%, P = 0.034). Tumor rupture, typical HCC enhancement patterns and portal vein tumor thrombosis were detected in 15.0% (3/20), 72.2% (13/18) and 20.0% (4/20) of patients with PCCCL and 3.1% (4/127), 83.6% (97/116) and 17.3% (22/127) of patients with CHCC, respectively. There were no significant differences between the two groups (all P > 0.05). No patients with PCCCL and 2.4% (3/127) of patients with CHCC showed signs of lymph node metastasis (P > 0.05). CONCLUSION: The imaging characteristics of PCCCL are similar to those of CHCC and could be useful for differentiating these from other liver tumors (such as hemangioma and hepatic metastases). PCCCLs are more prone than CHCCs to form pseudo capsules. AIM: To retrospectively analyze the computed tomography (CT) and magnetic resonance imaging (MRI) appearances of primary clear cell carcinoma of the liver (PCCCL) and compare the imaging appearances of PCCCL and common type hepatocellular carcinoma (CHCC) to determine whether any differences exist between the two groups. METHODS: Twenty cases with pathologically proven PCCCL and 127 cases with CHCC in the Second Affiliated Hospital of Sun Yat-sen University were included in this study. CT or MRI images from these patients were retrospectively analyzed. The following imaging findings were reviewed: the presence of liver cirrhosis, tumor size, the enhancement pattern on dynamic contrast scanning, the presence of pseudo capsules, tumor rupture, portal vein thrombosis and lymph node metastasis. RESULTS: Both PCCCL and CHCC were prone to occur in patients with liver cirrhosis, the association rate of liver cirrhosis was 80.0% and 78.7%, respectively (P 0.05). The mean sizes of PCCCL and CHCC tumors were (7.28 ± 4.25) cm and (6.96 ± 3.98) cm, respectively. Small HCCs were found in 25.0% (5/20) of PCCCL and 19.7% (25/127) of CHCC cases. No significant differences in mean size and ratio of small HCCs were found between the two groups (P = 0.658 and 0.803, respectively). Compared with CHCC patients, PCCCL patients were more prone to form pseudo capsules (49.6% vs 75.0%, P = 0.034). Tumor rupture, typical HCC enhancement patterns and portal vein tumor thrombosis were detected in 15.0% (3/20), 72.2% (13/18) and 20.0% (4/20) of patients with PCCCL and 3.1% (4/127), 83.6% (97/116) and 17.3% (22/127) of patients with CHCC, respectively. There were no significant differences between the two groups (all P 0.05). No patients with PCCCL and 2.4% (3/127) of patients with CHCC showed signs of lymph node metastasis (P 0.05). CONCLUSION: The imaging characteristics of PCCCL are similar to those of CHCC and could be useful for differentiating these from other liver tumors (such as hemangioma and hepatic metastases). PCCCLs are more prone than CHCCs to form pseudo capsules.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第7期946-952,共7页 世界胃肠病学杂志(英文版)
关键词 MRI图像 肝癌 CT 细胞 计算机断层扫描 磁共振成像 肝脏肿瘤 对比度增强 Clear cell carcinoma Hepatocellular carcinoma Pathology Magnetic resonance imaging Computed Tomography X-ray
  • 相关文献

参考文献3

二级参考文献80

  • 1[41]Chen SC,Lian SL,Chang WY.The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma.Cancer Chemother Pharmacol 1994;33Suppl:S124-S127
  • 2[42]Tazawa J,Maeda M,Sakai Y,Yamane M,Ohbayashi H,Kakinuma S,Miyasaka Y,Nagayama K,Enomoto N,Sato C.Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement.J Gastroenterol Hepatol 2001;16:660-665
  • 3[43]Yamada K,Soejima T,Sugimoto K,Mayahara H,Izaki K,Sasaki R,Maruta T,Matsumoto S,Hirota S,Sugimura K.Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma.Jpn J Clin Oncol 2001;31:147-152
  • 4[44]Ishikura S,Ogino T,Furuse J,Satake M,Baba S,Kawashima M,Nihei K,Ito Y,Maru Y,Ikeda H.Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus.Am J Clin Oncol 2002;25:189-193
  • 5[45]Yamada K,Izaki K,Sugimoto K,Mayahara H,Morita Y,Yoden E,Matsumoto S,Soejima T,Sugimura K.Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma.Int J Radiat Oncol Biol Phys 2003;57:113-119
  • 6[46]Nakagawa K,Yamashita H,Shiraishi K,Nakamura N,Tago M,Igaki H,Hosoi Y,Shiina S,Omata M,Makuuchi M,Ohtomo K.Radiation therapy for portal venous invasion by hepatocellular carcinoma.World J Gastroenterol 2005;11:7237-7241
  • 7[47]Zeng ZC,Fan J,Tang ZY,Zhou J,Qin LX,Wang JH,Sun HC,Wang BL,Zhang JY,Jiang GL,Wang YQ.A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.Int J Radiat Oncol Biol Phys 2005;61:432-443
  • 8[48]Lin CS,Jen YM,Chiu SY,Hwang JM,Chao HL,Lin HY,Shum WY.Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.Jpn J Clin Oncol 2006;36:212-217
  • 9[49]Hsu WC,Chan SC; Ting LL,Chung NN,Wang PM,Ying KS,Shin JS,Chao CJ,Lin GD.Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.Jpn J Clin Oncol 2006; 36:93-99
  • 10[50]Kim DY,Park W,Lim DH,Lee JH,Yoo BC,Paik SW,Kho KC,Kim TH,Ahn YC,Huh SJ.Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.Cancer 2005;103:2419-2426

共引文献115

同被引文献127

引证文献30

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部